Industry: Healthcare sector
Country of Origin: United States |
Target Areas: Worldwide
US Cancer company, combining bio-markers, micro-fluidics, cloud based storage and analytics and AI, require fund to the tune of US$ 10 to 15mn.
• USA based Point-of-care diagnostic company offering disruptive technology platform and cloud based reporting for screening of diseases like cancer
• Company has already been in existence over 5 years, has pumped in US$26mn to date and are ready to service first order received from the Gujarat Government for US$16mn
• Seven national and four in-licensed patents, four in-house patents filed and twenty trademarks
Revenue 2018: EUR 2,835,000
Capital / Loan Requirements: EUR EUR 12,500,000
Revenue Multiple 2018: 0.00
Only for REGISTERED USERS. If you are a REGISTERED USER please login. If you are not a REGISTERED USER and want to receive a more detailed business summary of this listing, please register.